Efficacy and Safety of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects with Type 2 Diabetes Mellitus

被引：0
|
作者：
Terra, Steven G.
Somayaji, Veena
Teeter, John G.
Dai, Haiqing
Nguyen, Tu T.
Ghazzi, Mahmoud
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A134 / A135
页数：2
相关论文
共 50 条
  • [41] A Comparative Study of Safety and Efficacy of Metformin Monotherapy Against Teneligliptin and Metformin in Type 2 Diabetes Mellitus
    Poornima, R.
    Brigida, S.
    Elizabeth, Arul Amutha
    Soujania, G.
    Lella, Tanuja
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 (02) : 7 - 12
  • [42] QSAR studies on pyrrolidine amides derivatives as DPP-IV inhibitors for type 2 diabetes
    Yang, Xiaoyan
    Li, Minjie
    Su, Qiang
    Wu, Milin
    Gu, Tianhong
    Lu, Wencong
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (11) : 5274 - 5283
  • [43] Incretin mimetics and DPP-IV inhibitors: New paradigms for the treatment of type 2 diabetes
    Hinnen, Deborah
    Nielsen, Loretta L.
    Waninger, Amy
    Kushner, Pamela
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2006, 19 (06) : 612 - 620
  • [44] Computational Identification of Inhibitors Against DPP-IV for Checking Type-2 Diabetes
    Gupta, Sarvesh Kumar
    Chaudhary, Kamal Kumar
    Raj, Utkarsh
    Mishra, Nidhi
    LETTERS IN DRUG DESIGN & DISCOVERY, 2017, 14 (01) : 66 - 73
  • [45] Comparison of the Efficacy and β-Cell Function In DPP-IV Inhibitors Treated Type 2 Diabetes Patients between Asian and Caucasian
    Cai, Xiaoling
    Han, Xueyao
    Luo, Yingying
    Ji, Linong
    DIABETES, 2013, 62 : A667 - A667
  • [46] Efficacy and safety of alogliptin, a potent and highly selective DPP-4 inhibitor, in Japanese patients with type 2 diabetes mellitus
    Seino, Y.
    Kaku, K.
    DIABETOLOGIA, 2010, 53
  • [47] Efficacy and Safety of Gosogliptin as Monotherapy and in Combination with Metformin in Patients with Type 2 Diabetes Mellitus
    Trakhtenberg, Julia
    Vostokova, Natalia
    Karavaeva, Oksana
    Kreminskaya, Vera
    Ametov, Alexander
    DIABETES, 2015, 64 : A329 - A330
  • [48] Safety and Efficacy of Metformin in Patients With Type 2 Diabetes Mellitus and Chronic Hepatitis C
    Harris, Kira
    Smith, Lisa
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (10) : 1348 - 1352
  • [49] In silico studies on the interaction between bioactive ligands and DPP-IV: insights on potential candidates for the treatment of type 2 diabetes mellitus
    Melo Reis Martins, Michelle Cristiane
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1331 - 1332
  • [50] Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes
    Scott, R.
    Loeys, T.
    Davies, M. J.
    Engel, S. S.
    DIABETES OBESITY & METABOLISM, 2008, 10 (10): : 959 - 969
12345